mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
temsirolimus |
GDSC1000 |
pan-cancer |
AAC |
-0.0096 |
0.8 |
mRNA |
etomoxir |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0097 |
0.8 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
BRD-K20514654 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.8 |
mRNA |
BI-2536 |
GDSC1000 |
pan-cancer |
AAC |
-0.015 |
0.8 |
mRNA |
BRD-K51831558 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.8 |
mRNA |
PD 153035 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |